HomeNews

News

Manufacturing

Production of Sputnik V abroad will be up to 6 mln doses a month from July

Pharma -
Via the Russian Direct Investment Fund, the authorities established a mechanism for using foreign sites, where the substance for the production of vaccines is sent to, the minister said.
Drug Development

Bharat Biotech’s vaccine Covaxin shows that it is 77.8% efficacy

Pharma -
The vaccine is produced with Bharat Biotech's in-house vero cell manufacturing platform that has the capacity to deliver about 300 million doses.
Manufacturing

Sputnik V certain copes with the Indian strain, expert says

Pharma -
The Sputnik V vaccine remained highly effective. According to the expert, it protects 100% from severe forms of the disease and deaths.
Drug Development

COVID-19 dual-antibody therapies prevent emergence of drug resistance

Pharma -
Administration of antibody therapies bypasses the body’s slower and sometimes less effective process of making its own antibodies.
Manufacturing

BIOCAD has presented the results of efficacy evaluation of the Russian immuno-oncology product prolgolimab for the treatment of melanoma

Pharma -
In the evening of June 21, 2021, leading Russian and international cancer experts presented the results of a three-year efficacy study of the Russian...
Global Markets

SK Bioscience to invest $132 million to beef up vaccine production capacity

Pharma -
SK Bioscience said the investment is meant to increase the production capacity of the production line based in Andong, about 270 kilometers south of Seoul.
1...129130131...141Page 130 of 141
spot_img

Expert Articles

spot_img